World Health Organization Sounds Alert Over Critical Lack of Weight-Loss Jabs
Under one in 10 patients that would benefit from GLP-1 drugs like Wegovy can access them, states the WHO as it releases its first recommendations on the therapies.
With in excess of 1,000,000,000 individuals worldwide currently classified as obese, it is advocating for increased and just availability to these injectable treatments.
Per projections, over two billion are projected to be living with obesity by 2030 if no action is taken.
"The latest guidelines recognises that excess weight is a lifelong illness that can be treated with thorough and ongoing support," stated its chief Tedros Adhanom Ghebreyesus.
High costs, constrained manufacturing, and distribution challenges are significant obstacles to broad access to the treatments that can aid individuals in losing substantial body mass, notes the body.
Skinny Jab Shortage
Even under the current most optimistic case, the manufacturing of these medications might only reach about 100 million people β less than 10% of eligible patients, per the health organization.
The recommendation calls on countries and companies to expand availability, by strategies including voluntary licensing.
A patent on the active ingredient β the core component of the drug Wegovy β is scheduled to end in a number of countries in 2026.
The Way Weight-Loss Jabs Operate
GLP-1 drugs mimick a body's own hormone to reduce digestion speed, curb appetite and enhance feelings of fullness so people eat less.
Patients typically begin shedding pounds after several weeks of starting on the weekly injections.
Studies suggests patients may see weight return after a year of stopping the treatment, when their normal food cravings come back.
Being overweight or obese increases your chance for experiencing health problems, such as diabetes, cardiovascular issues, brain attack, and certain malignancies.
Excess weight impacts individuals in all nations and was linked to over three and a half million deaths worldwide in 2024, per the health agency.
